WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV, ASX:PVA), a leader in the development of sustained release drug delivery products for the treatment of back-of-the-eye disease including the product candidate Iluvien™ for the treatment of Diabetic Macular Edema, today announced that its financial results for the first quarter of fiscal year 2011 will be released before the market opens on Friday, November 5, 2010, followed the same day by a conference call and live webcast scheduled for 8:30 a.m. ET.
